A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

January 10, 2025

Study Completion Date

January 10, 2026

Conditions

Multiple MyelomaMinimal Residual Disease

Trial Locations (1)

RECRUITING

The First Hospital of Jilin University, Changchun

All Listed Sponsors

lead

FengYan Jin

OTHER